Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
16 results
  1. Endometrial Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65829
    ... Grade and histological type are as follows: (1) Serous adenocarcinomas, clear cell adenocarcinomas, mesonephric-like carcinomas, gastrointestinal-type mucinous endometrial carcinoma, undifferentiated carcinomas, and carcinosarcomas are considered high ...
  2. BRCA1 and BRCA2: Cancer Risks and Management (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK589498
    ... W, Elit L, et al.: Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 79 (3): 477-81, 2000. [ PubMed : 11104623 ] Beiner ME, Finch A, Rosen B, et al.: The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. ...
  3. Childhood Ovarian Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK550996
    ... from malignant epithelial elements include the following types: Serous ... tumors, and adenocarcinomas. Most ovarian tumors in pediatric patients are benign ...
  4. Uterine Sarcoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65888
    ... is becoming similar to combined modality approaches for endometrial adenocarcinomas. Other rare forms of uterine sarcomas also fall ... is becoming similar to combined modality approaches for endometrial adenocarcinomas. Phase II chemotherapy studies by the Gynecologic Oncology ...
  5. List of Excluded Studies - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK82161
    ... in the tibia as a presenting sign of endometrial adenocarcinoma: a case report and the review of the ...
  6. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1247
    ... tube and primary peritoneal cancers). An excess of serous adenocarcinomas as opposed to mucinous or borderline tumors have ... Liu et al 2012 , McLaughlin et al 2013 ]. Serous adenocarcinomas are generally of higher grade and exhibit prominent ...
  7. Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK66007
    ... BRCA1 or BRCA2 proteins.[ 2 ] Therefore, high-grade serous adenocarcinomas arising from the fallopian tube and elsewhere in ... follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J Clin Oncol 10 (11): 1748-53, 1992. [ ...
  8. Endometrial Cancer Prevention (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66042
    ... PubMed : 28783542 ] Killackey MA, Hakes TB, Pierce VK: Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treat ...
  9. Genetics of Colorectal Cancer (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK126744
    ... most common extracolonic malignancy in Lynch syndrome is endometrial adenocarcinoma, which affects at least one female member in ... syndrome may include clear cell carcinoma, uterine papillary serous carcinoma, and ... Also, endometrial cancer most commonly arises from the lower uterine ...
  10. Diagnosis - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK82142
    ... for PLAP. Rates of immunoreactivity were: ovarian (both serous and mucinous adenocarcinoma), breast, gastric, colon, carcinomas. This high sensitivity suggests ...
previous · 1 · 2 · next